×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Biomarker
CTD_human
Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue.
20332317 2010
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Therapeutic
CTD_human
Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.
20197467 2010
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Therapeutic
CTD_human
Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue.
20332317 2010
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Therapeutic
CTD_human
Selective death of human breast cancer cells by lytic immunoliposomes: Correlation with their HER2 expression level.
19896266 2010
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Biomarker
CTD_human
Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.
20197467 2010
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Biomarker
CTD_human
Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins.
19801490 2009
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Therapeutic
CTD_human
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.
19436038 2009
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Biomarker
CTD_human
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.
19436038 2009
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Therapeutic
CTD_human
Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins.
19801490 2009
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Therapeutic
CTD_human
Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance.
19075277 2009
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Therapeutic
CTD_human
Mouse breast cancer model-dependent changes in metabolic syndrome-associated phenotypes caused by maternal dioxin exposure and dietary fat.
18840765 2009
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Biomarker
CTD_human
Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance.
19075277 2009
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Biomarker
CTD_human
Mouse breast cancer model-dependent changes in metabolic syndrome-associated phenotypes caused by maternal dioxin exposure and dietary fat.
18840765 2009
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Biomarker
CTD_human
Type 1 receptor tyrosine kinase profiles identify patients with enhanced benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial.
18768436 2008
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Therapeutic
CTD_human
Type 1 receptor tyrosine kinase profiles identify patients with enhanced benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial.
18768436 2008
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Therapeutic
CTD_human
[Efficacy and toxicity of trastuzumab combined vinorelbine in 21 patients with HER2 overexpressing metastatic breast cancer].
18819904 2008
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Biomarker
CTD_human
[Efficacy and toxicity of trastuzumab combined vinorelbine in 21 patients with HER2 overexpressing metastatic breast cancer].
18819904 2008
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Therapeutic
CTD_human
Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: the trastuzumab and vinorelbine or taxane study.
17614302 2007
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Biomarker
CTD_human
CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer.
18086299 2007
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Biomarker
CTD_human
Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: the trastuzumab and vinorelbine or taxane study.
17614302 2007
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Therapeutic
CTD_human
CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer.
18086299 2007
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Therapeutic
CTD_human
Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer.
16495393 2006
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Therapeutic
CTD_human
Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer.
16446318 2006
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Biomarker
CTD_human
Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer.
16495393 2006
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Therapeutic
CTD_human
Investigating the combination of trastuzumab and HER2/neu peptide vaccines for the treatment of breast cancer.
16865596 2006